Novel Strategies and Pharmaceutical Agents for the Treatment of Leishmaniasis: A Review

Author:

Nilforoushzadeh Mohammad A.1,Heidari-Kharaji Maryam1,Zare Mehrak1,Torkamaniha Elham1,Rafati Sima2

Affiliation:

1. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

2. Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran

Abstract

Leishmaniasis is a major tropical disease. There is no effective vaccine against leishmaniasis and chemotherapy is still the most effective treatment for the disease. However, most of the common drugs have many disadvantages such as toxicity and high cost. Most important of all is the development of resistance against these drugs. Many studies have tried to provide new pharmaceutical agents and formulations in various ways to overcome these problems. In recent years, medical plants have been widely considered for leishmaniasis treatment. Besides, various drug delivery strategies have been studied for the treatment of leishmaniasis in order to increase activity and reduce the side effects of the drugs. Accordingly, nanotechnology will play an important role in the preparation of new pharmaceutical formulations. In this review, we focused on various therapeutic approaches for leishmaniasis.

Publisher

Bentham Science Publishers Ltd.

Subject

Infectious Diseases,Pharmacology

Reference91 articles.

1. De Menezes J.P.B.; Guedes C.E.S.; Petersen A. L. d. O. A; Fraga D.B.M.; Veras P.S.T.; Advances in development of new treatment for leishmaniasis. BioMed Research International 2015,2015

2. Jaffary F.; Nilforoushzadeh M.A.; Moradi S.; Derakhshan R.; Ansari N.; The efficacy of topical treatment of concentrated boiled extract and hydroalcoholic extract of Cassia Fistula in comparison to the intralesional injection of meglumine antimoniate in the treatment of acute cutaneous Leishmaniasis. J Skin Leish 2010,1(1)

3. Fernandez M.; Murillo J.; Ríos-Vásquez L.A.; Ocampo-Cardona R.; Cedeño D.L.; Jones M.A.; Velez I.D.; Robledo S.M.; In vivo studies of the effectiveness of novel N-halomethylated and non-halomethylated quaternary ammonium salts in the topical treatment of cutaneous leishmaniasis. Parasitol Res 2018,117(1),273-286

4. Nilforoushzadeh M.A.; Shirani-Bidabadi L.; Zolfaghari-Baghbaderani A.; Saberi S.; Siadat A.H.; Mahmoudi M.; Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice. J Vector Borne Dis 2008,45(4),301-306

5. Nilforoushzadeh M.A.; Hejazi S.H.; Zarkoob H.; Shirani-Bidabadi L.; Jaffary F.; Efficacy of adding topical honey-based hydroalcoholic extract Nigella sativa 60% compared to honey alone in patients with cutaneous leishmaniasis receiving intralesional glucantime. J Skin Leish 2010,1(1),1-7

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3